Bone morphogenetic protein -4 and -5 in pancreatic cancer--novel bidirectional players (Q39518331)

12 September 2017

Bone morphogenetic protein -4 and -5 in pancreatic cancer--novel bidirectional players (English)

1 reference

12 September 2017

1 reference

Anne Kallioniemi

5

0 references

author name string

Siru Virtanen

1

1 reference

12 September 2017

Emma-Leena Alarmo

2

1 reference

12 September 2017

Saana Sandström

3

1 reference

12 September 2017

Minna Ampuja

4

1 reference

12 September 2017

language of work or name

English

0 references

publication date

17 June 2011

1 reference

Experimental Cell Research

12 September 2017

1 reference

12 September 2017

317

1 reference

12 September 2017

15

1 reference

12 September 2017

2136-2146

1 reference

Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens.

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Overview of bone morphogenetic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Signal transduction by bone morphogenetic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Signal transduction of bone morphogenetic protein receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Concise review: bone morphogenetic protein pleiotropism in neural stem cells and their derivatives--alternative pathways, convergent signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic proteins: multifunctional regulators of vertebrate development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic proteins and cancer: review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

The Yin and Yang of bone morphogenetic proteins in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic proteins and prostate cancer: evolving complexities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Prostate carcinoma skeletal metastases: cross-talk between tumor and bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Osteoblasts in prostate cancer metastasis to bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

BMP7 influences proliferation, migration, and invasion of breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic protein 4 induces epithelial-mesenchymal transition through MSX2 induction on pancreatic cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

PPM1D silencing by RNA interference inhibits proliferation and induces apoptosis in breast cancer cell lines with wild-type p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Overexpression of BMP-2/4, -5 and BMPR-IA associated with malignancy of oral epithelium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Functional implication of BMP4 expression on angiogenesis in malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Phenotype and genotype of pancreatic cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

The logic of TGFbeta signaling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Slow proliferation as a biological feature of colorectal cancer metastasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.06.001

10.1016/J.YEXCR.2011.06.001

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference